Alary P, Andersson J C
Centre Psychothérapique de l'Orne, Alençon.
Encephale. 1988 May-Jun;14(3):119-26.
The authors report a study, carried on more for than three years, concerning a long lasting experimentation with Clonidine as a prophylactic way. Seven patients, with affective disorders, isolated or joined to other psychiatrical affections were concerned. For four patients, the result is conclusive, the singularity of the Norepinephrine way in the Manic-Depressive illness being confirmed. To try to explain these results the authors suggest a critical model, including the receptor alpha 2 in its qualitative and quantitative aspects, probably modified by the permanent character of the treatment. More particularly, they postulate a dose-dependent activity of Clonidine, activity which could explain the noted alpha 2 pre- and probably postsynaptic effects.
作者报告了一项持续三年多的研究,该研究涉及以可乐定作为一种预防方法的长期试验。研究涉及七名患有情感障碍的患者,这些情感障碍或单独存在,或与其他精神疾病并发。对于四名患者,结果是决定性的,证实了去甲肾上腺素途径在躁郁症中的独特性。为了解释这些结果,作者提出了一个关键模型,包括α2受体在定性和定量方面的情况,其可能因治疗的持续性而发生改变。更具体地说,他们假设可乐定具有剂量依赖性活性,这种活性可以解释所观察到的α2突触前和可能的突触后效应。